Shanghai Kaibao: Announcement on changing the secretary of the company’s board of directors
Securities code: 300039 Securities abbreviation: Shanghai Kaibao Announcement number: 2026-028 Shanghai Kaibao Pharmaceutical Co., Ltd.
Announcement on Change of Secretary of the Company’s Board of Directors
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete, and contains no false records, misleading statements or major omissions.
Shanghai Kaibao Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the 14th meeting of the sixth board of directors on August 24, 2026, and reviewed and approved the "Proposal on Changing the Secretary of the Company's Board of Directors". The relevant situation is now announced as follows:
1. Regarding the resignation of the Secretary of the Board of Directors
The company's board of directors recently received the resignation report from Mr. Ren Liwang, the company's director and board secretary. Due to work adjustments, Mr. Ren Liwang resigned from the company's board secretary. After resigning from the above-mentioned position, he continued to serve as the company's director. Mr. Ren Liwang's original term of office as Secretary of the Board of Directors will end on the expiration date of the sixth term of the Company's Board of Directors. According to the relevant provisions of the Company Law and the Articles of Association, his resignation application will take effect from the date of delivery to the Company's Board of Directors.
As of the disclosure date of this announcement, Mr. Ren Liwang holds 1,675,392 shares of the company, accounting for 0.16% of the company's total share capital. There are no commitments that should be fulfilled but have not been fulfilled, and he strictly abides by the provisions of the Company Law, Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies and other relevant laws and regulations.
The work of Mr. Ren Liwang's board secretary has been successfully handed over, and his change of appointment will not affect the company's board of directors and the normal operation of the company. Mr. Ren Liwang performed his duties diligently and diligently during his tenure as secretary of the board of directors. The company's board of directors expresses its sincere gratitude to Mr. Ren Liwang for his contribution to the development of the company and the board of directors during his tenure as secretary of the board of directors!
2. Regarding the appointment of the secretary of the board of directors
The company held the 14th meeting of the sixth session of the Board of Directors on August 24, 2026, and reviewed and approved the "Proposal on Changing the Secretary of the Company's Board of Directors". After review and approval by the Nomination Committee of the Board of Directors, the Board of Directors agreed to appoint Ms. Liu Ting as the Secretary of the Company's Board of Directors (see the attachment for resume details). The term will be from the date of review and approval by the Company's Board of Directors to the expiration date of the Sixth Session of the Board of Directors.
Ms. Liu Ting has been engaged in capital market-related work for a long time. She has obtained the training certificate for board secretaries of listed companies issued by the Shenzhen Stock Exchange. She has good professional ethics and personal qualities, has the professional knowledge and work experience required to perform her duties, and is qualified for the job responsibilities. She is in compliance with the "Company Law of the People's Republic of China" The "Supervision Rules for Board Secretaries of Listed Companies" and "Shenzhen Stock Exchange Self-Discipline Supervision Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies" stipulate the qualification requirements for board secretaries. There are no circumstances in which they have been punished or punished by the China Securities Regulatory Commission, Shenzhen Stock Exchange and other relevant departments and are not suitable to serve as board secretaries. The contact information of the Board Secretary is as follows:
Tel: 021-37572069
Fax: 021-37572069
Email: [email protected]
Contact address: No. 88, Chengpu Road, Shanghai Comprehensive Industrial Development Zone
Announcement is hereby made.
Board of Directors of Shanghai Kaibao Pharmaceutical Co., Ltd.
August 24, 2026
Attachments:
Ms. Liu Ting’s resume
Ms. Liu Ting: Born in 1983, Chinese nationality, no permanent residence abroad, Master of Economics, Chinese Certified Public Accountant. From July 2010 to November 2025, he served as the business director and sponsor representative of the investment banking department of Soochow Securities Co., Ltd.; from December 2025 to March 2026, he served as the assistant general manager and sponsor representative of the investment banking department of Huayuan Securities Co., Ltd.; from March 2026 to the present, he served as the assistant general manager and investment director of Shanghai Kaibao Pharmaceutical Co., Ltd.
As of the date of this announcement, Ms. Liu Ting does not hold any shares in the company. There is no relationship with other directors, senior managers, shareholders and actual controllers holding more than 5% of the company's shares. There are no circumstances in which the Company Law, Shenzhen Stock Exchange Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operation of GEM Listed Companies, or Articles of Association prohibit serving as a senior manager of the company; he is not a person subject to enforcement for breach of trust, has not been banned from the securities market by the China Securities Regulatory Commission, has not been punished by the China Securities Regulatory Commission and other relevant departments, and has not been punished or publicly condemned by the stock exchange; nor has he been investigated by judicial authorities for suspected crimes or investigated by the China Securities Regulatory Commission for suspected violations of laws and regulations.